Export file:


  • RIS(for EndNote,Reference Manager,ProCite)
  • BibTex
  • Text


  • Citation Only
  • Citation and Abstract

Integrated network analysis to explore the key mRNAs and lncRNAs in acute myocardial infarction

1 Department of Cardiology, Anji People’s hospital, Huzhou, 313300, Zhejiang Province, China
2 Anji Branch Institute of The First Affiliated Hospital, Zhejiang University, Huzhou, 313300, Zhejiang Province, China
3 Department of Cardiology, Zhejiang hospital, Hangzhou, 310000, Zhejiang Province, China

# The authors contributed equally as joint first authors.

Special Issues: Advanced Big Data Analysis for Precision Medicine

Acute myocardial infarction (AMI) is the most severe cardiovascular event in the world. However, the molecular mechanisms underlying AMI remained largely unclear. Recently, long non-coding RNAs (lncRNAs) were reported to play important roles in human diseases. In the present work, we analyzed a public dataset GSE48060 to confirm key lncRNAs and mRNAs in AMI. We observed 4835 mRNAs and 442 lncRNAs were significantly differently expressed in AMI. Then, we for the first time constructed PPI networks and lncRNA co-expression networks in AMI. The protein-protein interaction (PPI) networks revealed several mRNAs such as RHOA, GNB1, GNG, RAC1, FBXO32, DET1, MEX3C and HECTD1 functioned as key regulators in AMI. LncRNA co-expression network analysis showed 8 lncRNAs (CA5BP1, LOC101927608, BZRAP1-AS1, EBLN3, FGD5-AS1, HNRNPU-AS1, LINC00342, and LOC101927204) played key roles in AMI. Gene ontology (GO) analysis demonstrated these differently expressed lncRNAs were associated with more signaling pathways, such as regulating transcription, protein amino acid phosphorylation, signal transduction, development. Taken together, our research unveiled a series of key lncRNAs and mRNAs in AMI. Several lncRNAs, including CA5BP1, LOC101927608, BZRAP1-AS1, EBLN3, FGD5-AS1, HNRNPU-AS1, LINC00342, and LOC101927204 were identified as key lncRNAs. PPI networks were constructed to reveal key mRNAs in AMI. These results provided useful information for exploring novel molecular target therapy for AMI.
  Article Metrics

Keywords differentially expressed gene; long non-coding RNA; acute myocardial infarction; protein-protein interaction analysis

Citation: Lishui Shen, Xiaofeng Hu, Ting Chen, Guilin Shen, Dong Cheng. Integrated network analysis to explore the key mRNAs and lncRNAs in acute myocardial infarction. Mathematical Biosciences and Engineering, 2019, 16(6): 6426-6437. doi: 10.3934/mbe.2019321


  • 1. G. W. Reed, J. E. Rossi and C. P. Cannon, Acute myocardial infarction, The Lancet, 389 (2017), 197–210.
  • 2. J. L. Anderson and D. A. Morrow, Acute myocardial infarction, N. Engl. J. Med., 376 (2017), 2053–2064.
  • 3. C. Basso, S. Rizzo and G. Thiene, The metamorphosis of myocardial infarction following coronary recanalization, Cardiovasc. Pathol., 19 (2010), 22–28.
  • 4. D. W. Kehl, N. Iqbal, A. Fard, et al., Biomarkers in acute myocardial injury, Transl. Res., 159 (2012), 252–264.
  • 5. S. Korff, H. A. Katus and E. Giannitsis, Differential diagnosis of elevated troponins, Heart, 92 (2006), 987–993.
  • 6. P. O'Brien, D. Smith, T. Knechtel, et al., Cardiac troponin I is a sensitive, specific biomarker of cardiac injury in laboratory animals, Lab. Anim-UK, 40 (2006), 153–171.
  • 7. M. Saito, T. Ishimitsu, J. Minami, et al., Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors, Atherosclerosis, 167 (2003), 73–79.
  • 8. V. A. Triant, H. Lee, C. Hadigan, et al., Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease, J. Clin. Endocr. Metab., 92 (2007), 2506–2512.
  • 9. R. B. Ramos, C. M. Strunz, S. D. Avakian, et al., B-type natriuretic peptide as a predictor of anterior wall location in patients with non-ST-elevation myocardial infarction, Clinics, 66 (2011), 437–441.
  • 10. O. M. Martins, V. F. Fonseca, I. Borges, et al., C-reactive protein predicts acute myocardial infarction in high-risk noncardiac and vascular surgery, Am. Heart Assoc., 2009.
  • 11. P. D. Zamore and B. Haley, Ribo-gnome: The big world of small RNAs, Science, 309 (2005), 1519–1524.
  • 12. T. Adachi, M. Nakanishi, Y. Otsuka, et al., Plasma microRNA 499 as a biomarker of acute myocardial infarction, Clin. Chem., 56 (2010), 1183–1185.
  • 13. M. Vausort, D. R. Wagner and Y. Devaux, Long noncoding RNAs in patients with acute myocardial infarction novelty and significance, Circ. Res., 115 (2014), 668–677.
  • 14. J. Liu, F. Sun, Y. Wang, et al., Suppression of microRNA-16 protects against acute myocardial infarction by reversing beta2-adrenergic receptor down-regulation in rats, Oncotarget, 8 (2017), 20122.
  • 15. A. E. Kornienko, P. M. Guenzl, D. P. Barlow, et al., Gene regulation by the act of long non-coding RNA transcription, BMC biol., 11 (2013), 59.
  • 16. K. C. Yang and J. M. Nerbonne, Mechanisms contributing to myocardial potassium channel diversity, regulation and remodeling, Trends Cardiovas. Med., 26 (2016), 209–218.
  • 17. Y. Guo, F. Luo, Q. Liu, et al., Regulatory non-coding RNAs in acute myocardial infarction, J. Cell Mol. Med., (2016).
  • 18. R. Suresh, X. Li, A. Chiriac, et al., Transcriptome from circulating cells suggests dysregulated pathways associated with long-term recurrent events following first-time myocardial infarction, J. Mol. Cell Cardiol., 74 (2014), 13–21.
  • 19. X. Zhang, S. Sun, J. K. Pu, et al., Long non-coding RNA expression profiles predict clinical phenotypes in glioma, Neurobiol. Dis., 48 (2012), 1–8.
  • 20. J. M. Wettenhalland G. K. Smyth, limmaGUI: A graphical user interface for linear modeling of microarray data, Bioinformatics, 20 (2004), 3705–3706.
  • 21. D. W. Huang, B. T. Sherman and R. A. Lempicki, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources, Nat. Protoc., 4 (2009), 44–57.
  • 22. D. Zhang, W. Ma, Y. He, et al., Data of the interacting protein networks and nucleotide metabolism pathways related to NDK and NT5, Data Brief, 9 (2016), 1063–1066.
  • 23. H. Yan, Z. Li, Q. Shen, et al., Aberrant expression of cell cycle and material metabolism-related genes contributes to hepatocellular carcinoma occurrence, Pathol. Res. Pract., 213 (2017), 316–321.
  • 24. M. Kohl, S. Wiese and B. Warscheid, Cytoscape: Software for visualization and analysis of biological networks, Methods Mol. Biol., 696 (2011), 291–303.
  • 25. D. Szklarczyk, A. Franceschini, S. Wyder, et al., STRING v10: protein-protein interaction networks, integrated over the tree of life, Nucleic. Acids Res., 43 (2014), D447–D452.
  • 26. X. Wangand L. Liotta, Clinical bioinformatics: a new emerging science, J. clin. Bioinform., 1 (2011), 1.
  • 27. J. R. Prensner and A. M. Chinnaiyan, The emergence of lncRNAs in cancer biology, Cancer Discov., 1 (2011), 391–407.
  • 28. M. Huarte, The emerging role of lncRNAs in cancer, Nat. Med., 21 (2015), 1253.
  • 29. A. Fatica and I. Bozzoni, Long non-coding RNAs: New players in cell differentiation and development, Nat. Rev. Genet., 15 (2014), 7.
  • 30. Q. Shi and X. Yang, Circulating microRNA and long noncoding RNA as biomarkers of cardiovascular diseases, J. Cell Physiol., 231 (2016), 751–755.
  • 31. K. Wang, C. Y. Liu, L. Y. Zhou, et al., APF lncRNA regulates autophagy and myocardial infarction by targeting miR-188-3p, Nat. Commun., 6 (2015), 6779.
  • 32. Y. Zhang, L. Sun, L. Xuan, et al., Reciprocal changes of circulating long non-coding RNAs ZFAS1 and CDR1AS predict acute myocardial infarction, Sci. Rep-UK, 6 (2016).


Reader Comments

your name: *   your email: *  

© 2019 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution Licese (http://creativecommons.org/licenses/by/4.0)

Download full text in PDF

Export Citation

Copyright © AIMS Press All Rights Reserved